Don’t slam baseball over drugs: an MLB investigation is what led to all of this

26 Comments

As has been the case with every single positive PED test involving a notable player over the past several years, I have no doubt that in the coming days we’ll see some variation of the following from a baseball writer:

Baseball wants you to think its drug problems are gone, but they’re not. With this latest story we now know that it’s as if it were 1998 all over again. Everyone is cheating and juicing and if you think that what you’re seeing on the field is genuine, think again.  Don’t let Bud Selig and Michael Weiner tell you that they have faith in the drug testing program. It’s all p.r. and it’s all bunk. We’re still in the Steroid Era.

I embellish, but only a little. We’ve all seen that sort of thing before and I assure you we’ll see it again.

But before you buy into that, go read Michael S. Schmidt’s report of this Miami business in the New York Times.  In addition to the things we already know, Schmidt reports that the reason this all came to light in the first place was because of an MLB investigation into an employee of Melky Cabrera’s agents in the wake of his positive test last year.

The upshot: MLB caught a cheating player with testing. Its investigations arm got involved and sniffed out the baloney in his story.  They dug deeper and made connections to past information they had on PED use but which was unactionable at the time. They brought in law enforcement to assist in the investigation.  The heat from that investigation led to this information coming out, and now they’re pledging to investigate further, with possible discipline to follow.

Some people may look at all of this as evidence of some epidemic and Major League Baseball being asleep at the switch.  I look at it as a pretty damn proactive and robust testing and investigative program doing the job it was set up to do.  Maybe that doesn’t make baseball 100% clean, but nothing in society is.  Heck, not even all sports is.  When was the last time the NFL, NBA or NHL was seen as being on top of things with respect to performance enhancing drugs as Major League Baseball is?  The most famous player in the Super Bowl just got linked to a banned PED today. We’ll hear little of this compared to the A-Rod business over the next week, I assure you.

Yet I expect people will still take their shots at MLB over all of this.  They’re so used to doing it, it’s hard to stop.

 

Report: Brewers sign Yovani Gallardo to a major league deal

Getty Images
4 Comments

Free agent right-hander Yovani Gallardo is headed back to the Brewers on a major league deal, The Athletic’s Ken Rosenthal reports. No other terms have been reported yet, as the agreement is still pending a physical.

Gallardo, 31, completed a one-year run with the Mariners before getting his $13 million option declined by the team last month. He provided little value during his time in Seattle, pitching to a 5-10 record in 22 starts and putting up a 5.72 ERA, 4.1 BB/9 and 6.5 SO/9 in 130 2/3 innings as both a starter and reliever.

Still, assuming the veteran righty is on the cusp of a comeback, he may as well try for it with his original club. Gallardo last appeared for the Brewers from 2007 to 2014, racking up a cumulative 20.8 fWAR and peaking during the 2010 season, when he earned his first All-Star nomination and Silver Slugger award. This will be his ninth career season with the club.

Even with Gallardo aboard, the Brewers are expected to continue deepening their pitching stores for 2018. With team ace Jimmy Nelson still recovering from shoulder surgery, the club will enter the season with a projected rotation of Gallardo, Zach Davies, Chase Anderson and Junior Guerra, the latter of whom pitched just 70 1/3 innings in 2017 following a right calf strain and shin contusion. Another big name pitcher could help cement Milwaukee’s rotation and keep them competitive for another year, though they don’t appear to have made any concrete moves in that direction so far.